Key result
Subsequent TAVI after distal radial balloon aortic valvuloplasty was associated with a non-significant reduction in all-cause mortality compared to BAV alone.
Why the study?
The long-term outcomes after distal radial balloon aortic valvuloplasty and the impact of subsequent TAVI in these patients remain unknown.
Does TAVI after distal radial balloon aortic valvuloplasty improve long-term mortality compared to BAV alone in patients with aortic stenosis?
Observational (n=30)
No
Does TAVI after distal radial balloon aortic valvuloplasty improve long-term mortality compared to BAV alone in patients with aortic stenosis?
Half of patients undergoing distal radial BAV eventually need TAVI within 5 months, and isolated BAV is associated with high short-term mortality (35.7%).
Answers are grounded in this paper and cite their sources.
Long-term DR BAV outcomes in 30 patients remain hypothesis-generating; leaves open durability and TAVI timing questions.
Background The benefits of distal radial balloon aortic valvuloplasty were recently reported: same efficacy as the classical femoral approach, with no vascular complications. The long-term outcomes for these patients remain unknown. Methods We retrospectively analyzed the long-term mortality and the impact of TAVI in a cohort of 30 patients who underwent distal radial (DR) BAV. Results The mean age was 78.3 ± 7.14 years and the median follow-up was 22.8 months. The indication for BAV was stable aortic stenosis in 70% of patients, while 23% of patients had concomitant acute heart failure symptoms and 6.6% of patients were in cardiogenic shock. A total of 16 patients (53.3%) received TAVI during follow-up after their BAV procedure while the remainder only received BAV. All-cause mortality was 20%, with only 1 death (6.3%) in the “BAV + TAVI” group compared to 5 deaths (35.7%) in the “BAV only” group (p = 0.089). All of the TAVI procedures were performed within 7 months after BAV. Cumulative incidence of TAVI was 40.0% at 5 months and 50.0% at 10 months. Cumulative incidence of death was 6.7% at 5 months, 13.3% at 10 months, 16.7% at 15 months, and 20.0% at 25 months. The probability of being alive without TAVI decreased from 53.3% at 5 months to 30.0% at 25 months. Conclusion In the present study, we could show that half of the patients undergoing BAV eventually need TAVI, most of them within 5 months after BAV, and that BAV remains associated with high mortality after the procedure, with 35% of those undergoing isolated BAV dying during short-term follow-up.
No takes yet. Share an insight, caveat, or question.
Achim et al. (2023) conducted an observational in Severe aortic stenosis (n=30). BAV + TAVI vs. BAV only was evaluated on All-cause mortality (p=0.089). Subsequent TAVI after distal radial balloon aortic valvuloplasty was associated with a non-significant reduction in all-cause mortality compared to BAV alone.
Synapse has enriched 10 related papers. Consider them for comparative context: